ACQUISITION OF THE ORAL SOLID MEDICATION TAPENTADOL 50 MG FOR THE MANTA GENERAL HOSPITAL

This tender, identified by process code SIE-HGM-2025-090-74622, focuses on the acquisition of a specific pharmaceutical product for the Manta General Hospital. The hospital requires the oral solid medication Tapentadol, specifically in a 50 mg dosage. Tapentadol is an analgesic used for moderate to severe pain management. The procurement specifies 57,000 milligrams of this medication. The contracting entity is the Manta General Hospital, and the procurement method is Electronic Reverse Auction. This acquisition is crucial for the hospital's pain management services, ensuring that patients suffering from significant pain have access to effective and appropriate pharmacological treatment. The availability of this medication supports post-operative care, chronic pain management, and palliative care services. The estimated cost for this procurement is USD 43,890.00. This tender reflects the hospital's commitment to providing comprehensive medical care, including effective pain relief, through the acquisition of essential pharmaceuticals.

This is a supplies contract in the governance and public administration sector. Located in Ecuador, Latin America, this opportunity is open to firms and consortiums.

Published through SERCOP Ecuador, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the governance and public administration sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.